Here are the four things to know:
1. Patients and physicians have both grown accustomed to treating pain with fast-acting drugs, according to Drs. Tick and Ballantyne.
“The business model of medicine encourages simple solutions to complex problems, and by all indications this approach is not helping patients,” they wrote in the op-ed.
2. However, opioids do not serve as an ideal treatment for chronic pain, as they become less effective and require ever-increasing doses to satisfy patients’ pain. In addition, the vast majority of prescribed drugs often produce side effects, which are then treated with more drugs. This cycle begins to feel like a game of Whac-A-Mole, the authors wrote.
3. Drs. Tick and Ballantyne refer to opioid overuse and poorly treated pain as twinned problems. They believe improving pain treatment requires a transformation in management strategies that encourage patients to take more ownership over their pain and treatment.
4. They concluded the healthcare industry must replace traditional opioid treatments with nanopharmaceutical solutions to better ensure patients’ long-term health.
More articles on opioids:
Viewpoint: Federal opioid response must address childhood trauma
Cryptomarket opioid sales increased after DEA tightened prescribing regulations
Study: New York physicians received $3.5M from opioid makers between 2013-15
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.